TAK - Takeda Pharmaceutical GAAP EPS of ¥150.00 revenue of ¥1.06T
2023-07-27 06:45:10 ET
- Takeda Pharmaceutical press release ( NYSE: TAK ): Q1 GAAP EPS of ¥150.00
- Revenue of ¥1.06T (+8.9% Y/Y).
- Revenue Growth of +8.9% at Actual Exchange Rate ( AER ); +3.7% Growth at Constant Exchange Rate (CER), Driven by Growth & Launch Products (+16.2% at CER)
For further details see:
Takeda Pharmaceutical GAAP EPS of ¥150.00, revenue of ¥1.06T